NIHR Patient Engagement in Clinical Development (PECD) Service – Document Review – supporting children to reach a healthy weight.

by Fraser Henderson | Dec 2, 2025 | Involvement

The National Institute for Health and Care Research (NIHR) is pleased to share an opportunity to be involved in the co-design of a commercial research study (that is a study funded by a pharmaceutical, biotechnology or medical device company) into supporting children...

NIHR Patient Engagement in Clinical Development (PECD) Service – Document Review – Haemophilia A or B

by Fraser Henderson | Nov 24, 2025 | Involvement

The National Institute for Health and Care Research (NIHR) is pleased to share an opportunity to be involved in the co-design of a commercial research study (that is a study funded by a pharmaceutical, biotechnology or medical device company) into Haemophilia,...

NIHR Patient Engagement in Clinical Development (PECD) Service – Document Review – Urothelial Cancer.

by Fraser Henderson | Nov 3, 2025 | Involvement

The National Institute for Health and Care Research (NIHR) is pleased to share an opportunity to be involved in the co-design of a commercial research study (that is a study funded by a pharmaceutical, biotechnology or medical device company) into Urothelial Cancer...

NIHR Patient Engagement in Clinical Development (PECD) Service – Document Review – Bowel Cancer

by Fraser Henderson | Oct 10, 2025 | Involvement

The National Institute for Health and Care Research (NIHR) is pleased to share an opportunity to be involved in the co-design of a commercial research study (that is a study funded by a pharmaceutical, biotechnology or medical device company) into Into Bowel Cancer,...

NIHR Patient Engagement in Clinical Development (PECD) Service – Document Review – Inflammatory Neuropathy known as CIDP

by Fraser Henderson | Oct 10, 2025 | Involvement

The National Institute for Health and Care Research (NIHR) is pleased to share an opportunity to be involved in the co-design of a commercial research study (that is a study funded by a pharmaceutical, biotechnology or medical device company) into Inflammatory...

Patient Advisory Group member to Lymphoma Benefits and Risks Team at Oxford Population Health, The University of Oxford

by Fraser Henderson | Oct 3, 2025 | Involvement

The Benefits and Risks Team at Oxford Population Health is a group of doctors, researchers, and patient partners who work together to understand the best ways to treat lymphoma. They look at both the good and the harmful effects of different treatments, using...